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Abstract
Many investigators are interested in combining biomarkers to predict an outcome of interest
or detect underlying disease. This endeavor is complicated by the fact that many biomarker
studies involve data from multiple centers. Depending upon the relationship between center, the
biomarkers, and the target of prediction, care must be taken when constructing and evaluating
combinations of biomarkers. We introduce a taxonomy to describe the role of center and
consider how a biomarker combination should be constructed and evaluated. We show that
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ignoring center, which is frequently done by clinical researchers, is often not appropriate. The
limited statistical literature proposes using random intercept logistic regression models, an
approach that we demonstrate is generally inadequate and may be misleading. We instead
propose using fixed intercept logistic regression, which appropriately accounts for center without
relying on untenable assumptions. After constructing the biomarker combination, we
recommend using performance measures that account for the multicenter nature of the data,
namely the center-adjusted area under the receiver operating characteristic curve. We apply
these methods to data from a multicenter study of acute kidney injury after cardiac surgery.
Appropriately accounting for center, both in construction and evaluation, may increase the
likelihood of identifying clinically useful biomarker combinations.
Keywords: biomarkers, combinations, diagnosis, multicenter, prognosis
1 Introduction
Biomedical investigations are often conducted in multiple centers (e.g., hospitals, clinics, providers).
For etiologic and therapeutic studies, there is a substantial literature on the challenges of a
multicenter study design. These challenges include correlations among observations from the same
center and the effect of differences across centers.1 The literature on multicenter studies is especially
extensive for randomized trials, where the need for careful design and analysis of such studies is
widely acknowledged.1
Multicenter biomarker studies are increasingly common as investigators seek to increase power and
generalizability (e.g., Feldstein et al.2, Degos et al.3, Nickolas et al.4). However, in contrast to
randomized trials, the literature on multicenter biomarker studies is small. As a cause or
consequence of this, the challenges and issues posed by a multicenter design appear not to be widely
appreciated among biomarker researchers. Furthermore, most biomarker studies measure many
2
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biomarkers. Since biomarkers often have only modest individual performance, investigators are
usually interested in constructing combinations of biomarkers. A multicenter study design can have
implications for both the construction and evaluation of biomarker combinations.
Center plays a unique role in biomarker studies, where the goal is generally prediction. Center may
be associated with the outcome one wants to predict, yet it cannot be used as a predictor. The
reason is that center does not generalize to patients from centers not in the study, so a prediction
instrument that used center as a predictor would not be broadly applicable. Recognizing this
situation, it seems many biomarker investigators decide to simply ignore the fact that their data
come from multiple centers. As we will demonstrate, ignoring center can produce misleading or
undesirable results. Although center cannot be used as a predictor, it generally must be accounted
for. However, not all methods for accounting for center are suitable for biomarker studies, and we
will illustrate shortcomings with some existing methods.
We will consider the role that center can play in multicenter biomarker studies, including proposing
a taxonomy that distinguishes different ways that center can be important and providing guidance
to researchers on identifying the role center may play in their studies. We assess the impact of
ignoring center and evaluate existing approaches for accounting for center in biomarker studies.
Finally, we propose suitable methods for constructing and evaluating biomarker combinations using
data from multiple centers. We restrict attention to biomarkers that will be used to identify
individuals likely to have (in the diagnostic setting) or develop (in the prognostic setting) some
clinical outcome; such biomarkers are sometimes referred to as “prognostic” or “diagnostic”
biomarkers, as opposed to biomarkers used to predict response to treatment, which are often called
“predictive” biomarkers.
This work was motivated by the Translational Research Investigating Biomarker Endpoints in Acute
Kidney Injury (TRIBE-AKI) study. The TRIBE-AKI study involves 1219 cardiac surgery patients
3
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at six centers in North America.5 The participants were followed for diagnosis of post-operative
acute kidney injury (AKI). For each patient, blood and urine were collected at multiple time points
pre- and post-operatively, and about two dozen biomarkers were measured at each time point. AKI
is typically diagnosed via changes in serum creatinine but these changes often do not happen until
several days after the injury.5 One goal of the study is to identify a combination of post-operative
biomarkers that can provide an earlier diagnosis of AKI.
2 Notation and Terminology
We discuss existing methods for (i) modeling clustered data and (ii) adjusting for covariates in
evaluating performance. We then apply these ideas to the multicenter setting, where center can be
thought of as both a clustering variable and a covariate. Below, we primarily use the term “cluster,”
though this is (for our purposes) interchangeable with “covariate.”
Let C indicate cluster and suppose the population consists of M clusters where cluster c has Nc
observations, c = 1, ...,M . Further suppose that we observe data from m of these clusters with nc
observations from cluster c, giving n total observations. We consider a p-dimensional vector of
predictors X and a binary outcome D. Cases (individuals who have or will develop the outcome) are
denoted by either D = 1 or the subscript D, while controls (individuals who do not have or will not
develop the outcome) are denoted by either D = 0 or the subscript D¯. Let (X, D) be the predictors
and outcome for an arbitrary observation. We use the subscript i on X and D to denote the
predictors and outcome, respectively, for the ith observation. We use the superscript c on X and D
to denote the predictors and outcome, respectively, for an observation from cluster c. We denote the
collection of predictors and outcomes for observations in cluster c as (X c,Dc).
In general, in the clustered data setting, predictors may be constant for all observations in a cluster
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(often called cluster-level, cluster-constant, or between-cluster predictors), may vary across
observations in a cluster (called cluster-varying or within-cluster predictors), or may vary both
within and between clusters. We focus on predictors that have at least some variation within
clusters. Throughout, we will assume a non-trivial cluster-specific prevalence of D; that is,
P (D = 1|C = c) := γc ∈ [1/V, 1− 1/V ], c = 1, ...,M , for some V ∈ (2,∞).
3 Background
3.1 Models for Clustered Data: Random Intercept Logistic
Regression
The random intercept logistic regression (RILR) model can be written as:
logit {P (D = 1|X, C = c, bc)} = bc + τ0 + τ>X, bc iid∼ F. (1)
Typically, it is assumed that bc ∼ N(0, σ2) so σ2 is an additional parameter in this model. If we
view the random intercept bc as σzc, where zc
iid∼ , σ is the regression coefficient for this standardized
omitted (cluster-level) predictor.6 In that sense, bc is generally “interpreted as the combined effects
of omitted cluster-level predictors.”7
3.1.1 Assumptions
The key assumptions typically made by the RILR model given in equation (1) are:8,9
(A1) bc and X c are independent
5
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(A2) bc
iid∼ N(0, σ2)
(A3) Conditional on (X c, bc), Dc1, ...Dcnc are independent and P (Dci = 1|X c, bc) = P (Dci = 1|Xci , bc),
i = 1, ..., nc
Assumption (A1) can be written as f(bc|X c) = f(bc), which is a fairly strong assumption in the
non-randomized setting.6 In particular, this assumption is often implausible when the distribution of
the predictors varies by cluster.
3.1.2 Estimates
It is important to distinguish between marginal and conditional modeling approaches: the
conditional (or cluster-specific) approach, for example, RILR, involves modeling the probability
distribution of D as a function of predictors and cluster-specific parameters (e.g., cluster-specific
intercepts), while the marginal (or population-averaged) approach involves modeling the marginal
expectation of D as a function of predictors.10 Due to the inclusion of cluster-specific parameters,
parameter interpretation under the conditional approach is with respect to cluster.10 For predictors
that vary within clusters, conditional methods are often more appropriate than marginal methods,
such as generalized estimating equations.10
Predictors frequently have both a between- and within-cluster component; that is, they vary both
within and between clusters.11 Estimates obtained via conditional methods are generally interpreted
as estimates of the within-cluster association, i.e., the association within each cluster, averaged
across clusters; this is typically what researchers are trying to estimate when they use these methods
with predictors that vary within clusters.1,12,13 However, as discussed below, estimated coefficients
obtained from RILR may not actually represent the within-cluster association: depending upon the
nature of the data, the resulting estimates are often a combination of within- and between-cluster
6
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variations.1,9–11,13–16 Importantly, between-cluster differences are likely to include the effects of
cluster-constant confounders.13
3.1.3 Violations of Assumptions
First we consider (A1); that is, independence of bc and X c. In the context of a randomized
multicenter clinical trial, the assumption holds if randomization is stratified by center, since in this
situation the distribution of the predictor, treatment, is the same across centers.1,11 However, as
noted above, it is generally the case predictors are not purely within-cluster and have both a
between-cluster component and a within-cluster component.11,17,18 When such predictors are
included in a RILR model, the assumption bc and X c are independent may not hold, leading to
distortions of the association of interest.11,17
As a concrete example, suppose the following model holds for the predictor X:
logit {P (D = 1|X,C = c, b′c)} = b′c + τ0 + τBh(X c) + τW (X − h(X c))
= b′c + τ0 + (τB − τW )h(X c) + τWX, (2)
where b′c ∼ N(0, σ2) and h(·) is some cluster-level summary of X c such that X − h(X c) has the same
distribution across clusters. Here, X − h(X c) corresponds to the within-cluster component of X and
h(X c) corresponds to the between-cluster component of X. If the distribution of the predictor X is
the same across clusters, then (τB − τW )h(X c) will be constant in large samples, and can be
combined with the fixed intercept τ0. However, if the distribution of the predictor varies across
clusters such that h(X c) varies and the RILR model given in equation (1) is fit to the data,
bc = b
′
c + (τB − τW )h(X c) which is not independent of X c if τB 6= τW , violating assumption
(A1).
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Results from research on omitted variable bias indicate that when (2) holds, and (1) is fit to the
data, the estimate of τW will be a combination of the within- and between-effects τB and τW .
11
Importantly, the combination of within- and between-effects, if these effects differ, is not of
substantive interest, lacking clinical relevance.1,11 Even in situations where it is thought that the
between- and within-cluster effects are reasonably close to one another, there is the potential for
differential confounding at the between- versus within-cluster level; thus, using both within- and
between-cluster comparisons to estimate the within-cluster effect is problematic.13,19 If cluster-level
factors are associated with predictors, as is often true in observational studies, the distribution of
the predictors is likely to vary across clusters, which may in turn lead to correlation between the
random intercepts and the predictors.7,16
This issue is often called “confounding by cluster” since the within-cluster association, τW , is
distorted by the between-cluster association, τB ;
1,9,17,20,21 in the econometrics literature, it is called
the “endogenous covariates problem.”7 In our example, omitting h(X c) leads to correlation between
bc and X c, which, as described by Greenland et al., has the effect of confounding τW .22 Thus,
confounders are “now covariates that ‘explain’ the correlation between” bc and X c;22 that is, the
cluster-level variable h(X c).
Assumption (A2) requires that the random cluster-specific intercepts be independently and
identically distributed according to a normal distribution with mean zero and variance σ2. Broadly
speaking, misspecifications of the random intercept distribution may lead to bias in the estimate of
the fixed intercept and the coefficients for cluster-level variables but typically do not have a large
effect on the estimates for cluster-varying predictors.6,18,23,24
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3.1.4 Decomposing Predictors
One solution that has been proposed to address violations of assumption (A1) is to decompose
predictors into a between-cluster component and a within-cluster component.6,9,11,14,16,18,19,25,26 In
the context of the model at (2), this means fitting a model with h(X c) and X as predictors. When
h(X c) = X¯ c, the cluster mean, this approach is called the “poor man’s” method.11 Using the cluster
mean may be overly simplistic17 and more flexible methods have been proposed based on modeling
bc as a function of X c.27 Of course, these methods require that the model for bc is correctly
specified.16,26,27
3.1.5 Efficiency
RILR is often touted as being more efficient than alternative methods due in part to the assumption
that bc has some (parametric) distribution.
12,28 In addition, RILR can use both between- and
within-cluster comparisons to estimate coefficients, which allows it to use more information in
estimating these parameters.8,9,12,29 Some studies have found reduced efficiency when the
distribution of the random intercept is not normal and normality is assumed.30
3.2 Models for Clustered Data: Fixed Intercept Logistic Regression
Fixed intercept logistic regression (FILR) can be used to model clustered data by including a fixed
intercept for each cluster. These models are a special case of generalized linear models. We consider
two variants of FILR: conditional (cFILR) and unconditional (uFILR). Both cFILR and uFILR have
the same model form:
logit {P (D = 1|X, C = c, βc0)} = βc0 + β>X, (3)
9
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where βc0 represents a cluster-specific intercept. The conditioning on β
c
0 in (3) is only necessary if β
c
0
is random. cFILR and uFILR differ in their approach to estimation: uFILR relies on the full
likelihood, while cFILR uses a conditional likelihood, conditioning on the number of cases in each
cluster.31
3.2.1 Assumptions
In the econometrics literature, the distinction between RILR and FILR is based not on whether the
cluster-specific intercepts are fixed or random, but whether they are independent of the predictors.8
Thus, the key assumption for FILR is:8,9
(B1) Conditional on X c, Dc1, ...Dcnc are independent
If the βc0 are random, then they must be independent across clusters and assumption (B1) must
additionally condition on βc0.
8,9
3.2.2 Estimates
FILR consistently estimates the within-cluster effect of predictors that vary within clusters, provided
(B1) is satisfied and model (3) holds.11,12,15,17 Thus, this method avoids the issue of confounding by
cluster; in fact, the resulting estimates are not subject to confounding by any unmeasured
cluster-constant variable.13,17
For both uFILR and cFILR, only within-cluster comparisons are used to estimate the coefficients,
and, since clusters for which all observations have D = 1 or all observations have D = 0 (we call
these “concordant clusters”) do not contribute any information to the estimation of the
within-cluster effect, they are not used in estimation.8,12 This is also true of clusters that are
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concordant on the predictors, though this situation is unlikely when there are multiple and/or
continuous predictors.
3.2.3 Efficiency
Many investigators are hesitant to use FILR since the exclusion of concordant clusters could reduce
efficiency.11 However, previous research has shown that cFILR provides estimates that are efficient
relative to RILR for predictors that vary predominantly within-clusters.19,32 Indeed, as pointed out
by Neuhaus and Kalbfleisch, for predictors with between- and within-cluster components, the
increased efficiency of estimates from RILR that is sometimes observed is often largely due to the
assumption of common within- and between-cluster effects.11 If these effects are indeed equal, there
will be some efficiency gain from using RILR since this approach uses both within- and
between-cluster variations to estimate the coefficients.19 However, as noted above, using both types
of variation in estimation is generally not recommended since the between and within effects may
not be equal and the potential exists for differential confounding. Furthermore, concordant clusters
contribute to between-cluster variation and often exhibit strong between-cluster effects, which have
the potential to heavily distort the estimated coefficients for predictors that vary within clusters if
RILR is used.14,15
3.3 Evaluating Performance
Suppose we have a predictor Z and are interested in evaluating its performance. Without loss of
generality, we will assume that higher values of Z are more indicative of D. We focus on
discrimination, since determining the discriminative ability of a predictor is often the first step in
developing a clinically useful diagnostic or prognostic tool. Discrimination is the ability of Z to
11
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separate cases and controls, and is commonly assessed via the area under the receiver operating
characteristic (ROC) curve (AUC). The ROC curve plots the true positive rate, the proportion of
correctly classified cases, versus the false positive rate, the proportion of incorrectly classified
controls, over the range of possible thresholds for Z.33 The ROC curve for a useless predictor is the
45-degree line, and the corresponding AUC is 0.5.33 The ROC curve for a perfect predictor reaches
the upper left-hand corner of the unit square, and the AUC for such a predictor is 1.33 The AUC
has a probabilistic interpretation: it is the probability that, for a randomly selected case and control,
the value of Z for the case is higher than the value of Z for the control.33
Covariate effects could influence the evaluation of the predictor Z; in particular, associations between
Z and the covariate could allow the covariate to contribute to or attenuate the discriminatory
accuracy of Z.34 In order to prevent the covariate from affecting the assessment of the discriminatory
accuracy of Z, the covariate-adjusted AUC should be evaluated. The covariate-adjusted ROC
(aROC) and corresponding covariate-adjusted AUC (aAUC) for a discrete covariate C, proposed by
Janes and Pepe, can be written as aROCZ and aAUCZ , respectively, where
35
aAUCZ =
∫ 1
0
aROCZ(t)dt =
∫ 1
0
∑
c
ROCZ|C=c(t)P (C = c|D = 1)dt
=
∑
c
wcAUCZ|C=c, (4)
where t denotes the false positive rate, ROCZ|C=c and AUCZ|C=c denote the covariate-specific ROC
and AUC, respectively, and wc = P (C = c|D = 1) denotes the distribution of the covariate among
cases. Thus, the aAUC is a weighted average of the covariate-specific AUCs, where the weights
correspond to the proportion of cases with each covariate value.35,36
When the same data are used to construct a combination and evaluate its performance, the resulting
estimate of performance is optimistic.37 This can be addressed by using a bootstrapping procedure
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to estimate the degree of optimism.37,38 Bootstrapping assumes observations are exchangeable,
which may not be reasonable when the data are clustered; thus, bootstrap resampling of clusters has
been suggested.1,36,39,40 However, Bouwmeester et al. found similar results for the average
cluster-specific AUC whether resampling was done on clusters or individual observations.39
4 Methods
Our predictors consist of a collection of biomarkers, and both the covariate and the cluster variable
are center.
When the data come from a single center, common practice is to first construct a combination of the
biomarkers, often using logistic regression, and evaluate its performance using measures such as the
AUC. With more than one center, it is important to consider how to appropriately accommodate
center in both the construction and evaluation of biomarker combinations. As with the
center-adjusted odds ratio in multicenter etiologic studies or the center-adjusted treatment effect in
multicenter randomized trials, we propose using conditional approaches in the construction and
evaluation of biomarker combinations; in particular, we propose using FILR to construct biomarker
combinations and the center-adjusted AUC to evaluate them.
Throughout, we focus on constructing a single biomarker combination; that is, we do not allow the
relationship between the biomarkers and the outcome to vary across centers. In the clinical trial
setting, assessing treatment-by-center interactions is usually not part of the primary analysis.29
Analogously, in the diagnostic and prognostic settings, it is preferable to give a single combination
that is not center-specific, as this would make combination development highly localized. We focus
on constructing linear combinations via the logistic regression framework. While this may seem
restrictive, Pepe et al. noted that the class of linear combinations is actually quite large (taking into
13
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consideration possible biomarker transformations and interactions) and the logistic form is fairly
robust.41
4.1 The Role of Center
We consider the role of center in the context of two sets of characteristics:
1. Characteristics affecting the prevalence of D: differences in the populations served by each
center could affect the prevalence of D.
2. Characteristics affecting biomarker measurements: center-level factors, including storage and
handling of specimens and practices in each center, could lead to variations in biomarker
measurements unrelated to D.
We focus on three possibilities for the role of center. We call center a confounder when it affects
both the prevalence of D and biomarker measurements, a case mix variable when it affects only the
prevalence of D, and a calibration variable when it affects only the biomarker measurements.
In the TRIBE-AKI study, where the goal is to use biomarkers to diagnose AKI, certain centers may
serve particularly unhealthy communities and that this results in differences in biomarker levels
across center; however, these differences may reflect true underlying biology. If factors such as
storage and handling of biomarkers and surgical practices are standardized, such that the
distribution of biomarkers is similar across centers, conditional on case status, center would be a
case mix variable. If, however, these factors vary across centers (e.g., in some centers surgeons use
different protocols for fluid administration) in addition to variability in disease prevalence, center
would be a confounder. On the other hand, if the populations served by each center are relatively
similar in terms of underlying AKI risk, but factors such as surgical protocols vary across centers
14
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and lead to variations in biomarker measurements, center would be a calibration variable.
In Figure 1, we present graphical and probabilistic depictions of center as a case mix variable, a
calibration variable, and a confounder for diagnostic or prognostic biomarkers X. Diagnostic
biomarkers represent some underlying disease or disease process, that is, D → X, while prognostic
biomarkers that cause some future outcome, that is, X→ D.
Figure 1: Select potential roles of center in biomarker studies.
It is important to distinguish center as a confounder, as defined in Figure 1, from “confounding by
cluster” in the context of a RILR model. Our use of “confounding” in Figure 1 is in line with
standard epidemiological notions of confounding, where a variable C distorts the effect of interest,
the causal association between X and D. The idea of “confounding by cluster” for RILR models, on
the other hand, is specific to the RILR framework: “confounding by cluster” occurs when the
15
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random intercepts and the biomarkers are not independent, leading to distortion of the effect of
interest, the within-cluster association. As we will see, there are situations where center is not a
confounder by the definitions in Figure 1, but the random intercepts and the biomarkers may not be
independent, so in the context of the RILR model, we are susceptible to “confounding by
cluster.”
4.2 Ignoring Center
Clinical researchers frequently ignore center in the construction and/or evaluation of combinations of
diagnostic or prognostic biomarkers (e.g., Shapiro et al.42 and Vuilleumier at al.43). This is likely
due to the fact that investigators acknowledge that center should not na¨ıvely be included as a
predictor, but are not familiar with methods for accommodating center or the repercussions of
ignoring it.
4.2.1 Construction
Suppose the linear-logistic model holds:
logit {P (D = 1|X, C = c, βc0)} = βc0 + β>X. (5)
Such a model could arise from the following data-generating model for two biomarkers,
X = (X1, X2):
 X1
X2
∣∣∣∣∣∣∣D = d,C = c
 ∼ N

 fX1(c) + µX1d
fX2(c) + µX2d
 ,
 1 ρ
ρ 1

 (6)
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where µX1 and µX2 are related to the center-specific AUC for each marker: µX1 =
√
2Φ−1(λ1) and
µX2 =
√
2Φ−1(λ2), where Φ is the standard normal distribution function and λ1 and λ2 are the
center-specific AUCs for X1 and X2, respectively. Thus, we consider constant center-specific AUCs
for X1 and X2, and allowing for center effects on biomarker levels via conditional mean shifts (f(c)).
Equation (6) gives
logit {P (D = 1|X, C = c, βc0)} = βc0 + β1X1 + β2X2.
where βc0 is a center-specific offset and, as shown in the Supplementary Materials (S1),
βc0 =
−µ2X1 − µ2X2
2(1− ρ2) +
ρµX1µX2 + ρµX1fX2(c) + ρµX2fX1(c)
1− ρ2
− {µX1fX1(c) + µX2fX2(c)}
1− ρ2 + log
(
γc
1− γc
)
,
and
β1 =
µX1 − ρµX2
1− ρ2 , β2 =
µX2 − ρµX1
1− ρ2 .
Returning to the general linear-logistic model given in (5), suppose that the model holds, but βc0 is
not allowed to vary across centers. That is, suppose we fit the following model to the data pooled
across centers:
logit {P (D = 1|X)} = α0 + α>X. (7)
When C and D are independent conditional on X or C and X are independent conditional on D,
and model (5) holds, we have collapsibility,44 so the conditional and marginal coefficients are the
same (α = β) and the marginal logit, logit{P (D = 1|X)}, is still linear. Therefore, in these
situations, the relationship between the biomarkers and the outcome is the same whether or not we
condition on center. Furthermore, under model (5), when C and D are independent conditional on
X, βc0 will not vary across centers, so α0 = β
c
0.
17
Hosted by The Berkeley Electronic Press
However, when model (5) holds yet C and D are not independent conditional on X and C and X
are not independent conditional on D, we may no longer have α = β. Furthermore, the
linear-logistic model (5) may not hold, in which case the results on collapsibility will no longer be
expected to apply. More generally, ignoring center in the construction of the biomarker combination
potentially allows center to be predictive; that is, part of the effect of center may be included in the
estimates of the biomarker coefficients when center is omitted.
4.2.2 Evaluation
Suppose p = 2 and we have a linear combination: Lθ(X) = θ
>X = θ1X1 + θ2X2. When center is
ignored in the evaluation of Lθ(X), the data are pooled across centers, giving the marginal AUC,
AUC(θ) = P (Lθ(XD) > Lθ(XD¯)). In practice, AUC(θ) is estimated empirically:
ˆAUC(θ) =
∑nD
i=1
∑nD¯
j=1 1(Lθ(XDi) > Lθ(XD¯j))
nDnD¯
,
where 1(a > b) is 1 if a > b and 0 otherwise. If the Lθ(X) is associated with center, the marginal
AUC may not reflect the center-specific AUC.34
4.3 Accounting for Center
Often, multicenter studies of association account for center in some way, typically by estimating a
center-adjusted measure of association. In multicenter randomized trials, randomization is often
stratified by center and the target of estimation is then the center-adjusted treatment effect.29 This
idea can be extended to the construction and evaluation of biomarker combinations for diagnosis
and prognosis. In particular, we focus on methods that stratify (condition) on center in both the
18
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construction and evaluation of biomarker combinations.
4.3.1 Construction
We will consider two methods for constructing combinations that involve conditioning on center,
namely, RILR and FILR; for FILR, we will consider both cFILR and uFILR. For concreteness, we
consider p = 2 in the discussion below.
4.3.2 Construction: RILR
To the extent that the literature has acknowledged the potential role of center in the prediction
setting, RILR is often the approach used in constructing combinations.45 This model can be written
as
logit {P (D = 1|X, C = c, bc)} = bc + τ0 + τ1X1 + τ2X2,
bc
iid∼ F (0, σ2), (8)
where the distribution of the random center-specific intercepts. The model makes three key
assumptions, (A1)–(A3). In general, when the distribution of X1 or X2 varies by center, assumption
(A1) may not hold and the corresponding estimates (τˆ0, τˆ1, τˆ2) may not be meaningful.
The “poor man’s” method may be useful in addressing violations of (A1), and can be written
logit {P (D = 1|X1, X2, b∗c)} = b∗c + τ∗0 + τW1 (X1 − X¯c1) + τW2 (X2 − X¯c2) + τB1 X¯c1 + τB2 X¯c2 ,
b∗c ∼F (0, σ∗2),
19
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where X¯c1 and X¯
c
2 are the means of X1 and X2 in center c, respectively, b
∗
c represents the random
intercept in center c, τ∗0 represents the overall (fixed) intercept, τ
W
1 and τ
W
2 represent the
within-center effects of the biomarkers, and τB1 and τ
B
2 represent the between-center effects of the
biomarkers.
4.3.3 Construction: FILR
An option that has been discussed at length in the literature on multicenter randomized trials,1,11,17
but has been largely (if not entirely) neglected in the prediction literature is FILR. We propose
using uFILR when the number of centers is modest, and cFILR when the number of centers is large
in order to avoid the incidental parameters problem.31 The FILR model can be written as
logit {P (D = 1|X, C = c, βc0)} = βc0 + β1X1 + β2X2.
If the βc0 are not random, this model relies on assumption (B1).
4.3.4 RILR vs. FILR in Diagnostic and Prognostic Research
Random intercept models are, at first glance, appealing in the context of prediction when the data
arise from multiple centers: these models are thought to represent a situation where there exists a
large population of centers, and the data at hand constitute a random draw of centers from that
population. This intuition may make investigators more comfortable with generalizing their results
to centers not included in their data, typically the goal of prediction research, and thus more likely
to use RILR. However, the key distinction between random and fixed intercept models is not
necessarily whether the center-specific intercepts are random or fixed, but rather whether they are
associated with the biomarkers.8 Thus, while the notion of center-specific intercepts as random
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quantities may have intuitive appeal, this is outweighed by the statistical reality that random
intercept models rely on potentially untenable assumptions.
Researchers may also be drawn to RILR since it gives an estimate of the overall intercept τ0 and the
center-specific intercepts bc are typically assumed to be normally distributed with mean 0; this leads
researchers to believe that they can provide predicted probabilities for patients in new centers not
used in model fitting via τˆ0 + τˆ1X1 + τˆ2X2. However, assuming bc = 0 in new centers generally leads
to poor calibration; that is, it does not provide useful estimates of P (D = 1|X).21 Even if a valid
estimate of bc is available, the estimate of τ0 from RILR can be badly biased if the random intercept
distribution is misspecified.
The “poor man’s” method has been proposed as an alternative to standard RILR. Even if the
distributions of the mean-centered predictors are the same across centers (which would help to
address violations of assumption (A1)), this method is not particularly compelling in the prediction
setting since application of the model to new centers requires estimates of the center-specific
biomarker means; such reliance on information from the new center makes external validation and
clinical application (if predicted probabilities are sought) more challenging. In addition, since the
“poor man’s” method still relies on a RILR model, the estimate of the fixed intercept may face the
same challenges as with the standard RILR model.
The goal of the poor man’s method is to transform the biomarkers into predictors that are
independent of bc. This is an attempt to force the model to estimate the within-center effect of the
biomarkers, as opposed to a combination of the within- and between-center effects. However, FILR
estimates the within-center effect with no further assumptions or transformations of the data. This
is compelling as estimates of biomarker associations (and thus, fitted biomarker combinations) that
are unaffected by center differences are most useful in identifying promising combinations for further
development.
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Conversely, an obvious criticism of FILR is that it does not allow predicted probabilities to be
calculated either in new centers (for uFILR) or at all (for cFILR). However, as discussed above,
RILR does not necessarily solve this problem. Furthermore, the biomarker combination can still be
useful, for example, to stratify patients within each center according to likelihood of having or
developing the outcome.
4.3.5 Evaluation: Center-Adjusted ROC and AUC
When the data come from multiple centers, it is important to avoid allowing center to be predictive,
so conditional approaches to constructing combinations are appropriate. Likewise, in order to
prevent center differences from affecting the assessment of the discriminatory accuracy of a fitted
combination, a conditional measure should be used to evaluate performance. In particular, the
marginal AUC would be appropriate if between-center heterogeneity were able to be used in making
decisions, but this is not typically true.46 Thus, some summary of the conditional, or center-specific,
AUCs should be used to avoid allowing center differences to influence the evaluation of performance.
The summary measure defined in equation (4), that is, using the distribution of center among cases
to weight the center-specific AUCs, is compelling because it is the area under the ROC curve
corresponding to the true and false positive rates based on center-specific thresholds; these
center-specific thresholds are chosen such that the false positive rate is the same in each center.35
That is, for a predictor Z, we can write aROCZ(t) = P
(
Z > gc(t)
∣∣∣D = 1), where gc(t) is the
center-specific threshold giving a false positive rate of t in center c.
For a given combination Lθ(X) = θ
>X, the center-adjusted AUC can be written as
aAUC(θ) =
∑M
c=1 wcAUCc(θ) where the center-specific AUC is AUCc(θ) = P (Lθ(X
c
D) > Lθ(X
c
D¯)).
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In practice, AUCc(θ) is estimated empirically:
ˆAUCc(θ) =
∑ncD
i=1
∑nc
D¯
j=1 1(Lθ(X
c
Di) > Lθ(X
c
D¯j)
ncDn
c
D¯
.
The empirical aAUC estimate is then
ˆaAUC(θ) =
m∑
c=1
wˆc ˆAUCc(θ),
where wˆc is the fraction of observed cases in center c and is the empirical estimate of the weight wc,
that is, wˆc =
ncD
nD
. The AUCc can only be estimated in discordant centers.
When the ROC curve varies by a covariate, it is generally recommended that a separate ROC curve
be estimated for each value of the covariate.36 In the case of center, where only a fraction of the
centers are observed, this is not possible. However, it is reasonable to assess the heterogeneity in the
center-specific AUCs, as this provides some indication of how the predictor may perform in a new
center.45
Finally, as a consequence of focusing on the center-specific AUC, summarized via the aAUC, we do
not need an estimate of the center-specific intercept to evaluate a combination, as the center-specific
AUC is a rank-based measure and so would be unaffected by such offsets. This allows for
identification of promising combinations of biomarkers for further development without the need for
center-specific intercept estimates.
4.3.6 Asymptotic Properties
Our proposal involves constructing linear combinations of biomarkers by estimating θ and
evaluating the performance of these combinations with the aAUC. We would like to demonstrate
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consistency of this estimate of performance; that is, ˆaAUC(θˆ) converges in probability to aAUC(θ0)
if θˆ converges in probability to θ0. This is shown by Lemma 1 and Theorems 1 and 2, which are
stated and proved in the Supplementary Material (S2).
4.4 Combining Construction and Evaluation
When constructing and evaluating biomarker combinations, there are two binary decisions to make
regarding center, giving four possibilities (using the notation of models (5) and (7)):
1. Pool the data across centers for both construction and evaluation, giving AUC(α)
2. Pool the data across centers for construction, but stratify by center for evaluation, giving
aAUC(α)
3. Stratify by center for construction, but pool across centers for evaluation, giving AUC(β)
4. Stratify by center for both construction and evaluation, giving aAUC(β)
Proposition 1, given in the Supplementary Material (S3), follows directly from Pepe33 and shows
that the marginal and center-adjusted AUCs of a combination based on some θ are equivalent if C
and Lθ(X) are independent among controls. If C and X are independent conditional on D, then C
and Lθ(X) will be independent among controls. Thus, if model (5) holds and C and X are
independent conditional on D, then AUC(β) = aAUC(β) = aAUC(α) = AUC(α), since α = β by
collapsibility. Proposition 2, given in the Supplementary Material (S3), also follows directly from
Pepe33 and shows that when the prevalence and center-specific AUC do not vary with center and
the center-specific ROC curves are concave, the aAUC for a given biomarker combination will be at
least as large as the marginal AUC. In general, the center-specific ROC curves will be concave if for
a given θ, in each center, increasing Lθ(X) increases the likelihood that D = 1.
37
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When model (5) holds, optimality of the risk score P (D = 1|X, C = c, βc0) implies that the
combination based on β is optimal within each center, in terms of maximizing center-specific
AUC.33,47 Thus, under this model,
aAUC(β) ≥ aAUC(θ),
for any θ. Furthermore, by the collapsibility results discussed above, when model (5) holds and C
and D are independent conditional on X, α = β, so
AUC(α) = AUC(β)
aAUC(α) = aAUC(β).
5 Simulations
5.1 Ignoring Center
We studied the impact of ignoring center in the construction and/or evaluation of biomarker
combinations. We considered diagnostic markers, and allowed center to be a case mix variable, a
calibration variable, or a confounder (as summarized in Figure 1). The two biomarkers X1 and X2
were distributed as described in equation (6) with ρ = 0.5, and λ1 = 0.6 and λ2 = 0.65 in all
centers.
Throughout, fX1(c) = fX2(c) = f(c). When center was a case mix variable, logit(γc) ∼ N(0, σ2γc)
and f(c) = 0. When center was a calibration variable, γc = 0.5 and f(c) ∼ N(0, σ2f(c)). Finally, when
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center was a confounder,
 logit(γc)
f(c)
 ∼ N

 0
0
 ,
 σ2γc δσγcσf(c)
δσγcσf(c) σ
2
f(c)

 .
We considered σ2γc = 1, σ
2
f(c) = 5, and δ ∈ {−0.75, 0.75}.
We constructed combinations in a training dataset consisting of either 6 centers with 200
observations each or 500 centers with 20 observations each. The combinations were constructed via
logistic regression, where center was either ignored or incorporated using FILR (uFILR for m = 6
and cFILR for m = 500). These estimates correspond to estimates of α and β (defined in equations
(7) and (5)), respectively.
We evaluated fitted combinations via the conditional AUC, AUCc(·), in a large test dataset with a
single center, and the marginal AUC, AUC(·), in a large test dataset with multiple centers. As
shown in the Supplementary Material (S4), the conditional AUC is constant across centers under
our data-generating model so AUCc(·) = aAUC(·). The test set used to evaluate the conditional
AUC consisted of a single center with 200 000 observations while the test set used to evaluate the
marginal AUC included either 6 centers with 30 000 observations each or 500 centers with 400
observations each, depending on the structure of the training data. The observations in the test data
represent subjects from new centers, i.e., not the same centers as used in the training data. The true
coefficients β = (β1, β2) and AUCc(β) were determined analytically for comparison. The simulations
were repeated 500 times.
Figure 2 presents the results of the simulations with 500 centers. These simulations support the
conclusions given above: that is, when center is a case mix variable, the combination and its
performance (in terms of the AUC) are not affected by ignoring center in construction and/or
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evaluation. Likewise, the simulation results when center is a calibration variable are consistent with
the relationships described above, that is, AUCc(βˆ) ≥ AUCc(αˆ), AUCc(βˆ) ≥ AUC(βˆ) and
AUCc(αˆ) ≥ AUC(αˆ). Thus, when center is a calibration variable, ignoring center during
construction can lead to a biomarker combination with reduced predictive capacity in new centers,
and ignoring center during evaluation yields a measure of performance that is lower than the actual
performance of the combination in a new center.
Figure 2: Simulation results for training data with 500 centers. The first column, AUC(αˆ), is the
marginal AUC based on the combination constructed by ignoring center and the second column,
AUCc(αˆ), is the conditional AUC based on the combination constructed by ignoring center. The
third column, AUC(βˆ), is the marginal AUC based on the combination constructed by stratifying by
center and the fourth column, AUCc(βˆ), is the conditional AUC based on the combination constructed
by stratifying by center. For each, the median and middle 90% of the distribution across simulations
are shown. Different colors and shapes correspond to different roles for center: blue circles indicate
center is a case mix variable, red squares indicate center is a calibration variable, purple triangles
indicate center is a confounder with positive correlation (0.75) between logit(γc), and f(c) and green
diamonds indicate center is a confounder with negative correlation (−0.75) between logit(γc) and f(c).
The gray horizontal line represents AUCc(β) as determined analytically.
27
Hosted by The Berkeley Electronic Press
When center is a confounder and center is ignored during construction (yielding αˆ), further ignoring
center during evaluation tends to give a measure of performance that is higher than the actual
performance in a new center (i.e., AUC(αˆ) tends to be larger than AUCc(αˆ)). On the other hand, if
center is included in construction (yielding βˆ), ignoring center during evaluation can give a measure
of performance that may be higher or lower than the performance of the combination in a new
center; that is, AUC(βˆ) may be larger or smaller than than AUCc(βˆ), depending on the correlation
δ. As expected, ignoring center during construction generally results in a combination with worse
performance in new centers (AUCc(αˆ) vs. AUCc(βˆ)).
Supplementary Material (S5.1) gives the full results.
5.2 Including Center
We conducted simulations to compare combinations constructed by RILR to those constructed by
FILR. The set-up of these simulations is similar to those described in Section 5.1. When center was
a case mix variable, logit(γc) ∼ F with mean 0 and variance σ2γc and f(c) = 0. When center was a
calibration variable, γc = 0.5 or 0.1 and f(c) ∼ F with mean 0 and variance σ2f(c). Finally, when
center was a confounder, logit(γc) ∼ F with mean 0 and variance σ2γc , f(c) ∼ F with mean 0 and
variance σ2f(c), and Corr(logit(γc), f(c)) = δ. We varied F (Normal, Gumbel, Laplace, or Uniform),
σ2γc (0.5, 1, 3, (0.5, 1.5), or (1, 5)), σ
2
f(c) (1, 5, or (2,8)) and δ (−0.5, 0, 0.5). We considered some
settings where the variances of logit(γc) (or f(c)) were not constant (those pairs of values in
parentheses); in these scenarios, half of the centers were assigned one value of σ2γc (or σ
2
f(c)) and the
remainder were assigned the other. When center was a calibration variable, γc = 0.5 in most
simulations; however, to study the impact of concordance, we also considered simulations where
γc = 0.1. This was also the motivation for including large values of σ
2
γc .
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Linear combinations were constructed in training data (which had either 6 or 200 centers) via
logistic regression, where center was either (i) incorporated using RILR assuming bc
iid∼ N(0, σ2) or
(ii) incorporated using uFILR (in the case of 6 centers) or cFILR (in the case of 500 centers). The
fitted biomarker combinations based on RILR and FILR were evaluated in test data, which consisted
of a single new center with 10 000 observations. These simulations were repeated 500 times.
In Figure 3, we present the results for m = 500 centers in the training data with F = Normal,
σ2γc = 1, σ
2
f(c) = 5, γc = 0.5 when center was a calibration variable, and δ = −0.5 when center was a
confounder. In all scenarios, the results from FILR are close to the true values. The differences in
the coefficient estimates when RILR is used are clear, particularly when center is a calibration
variable or a confounder. This leads to substantially different conditional AUCs for RILR compared
to FILR, particularly when center is a calibration variable. The differences in AUC are small when
center is a case mix variable; in this setting, the differences in the coefficient estimates are not as
large, and the AUC, which is a rank-based measure, can overcome these more modest perturbations.
Additionally, the differences in the coefficient estimates and the AUC are much larger when center is
a calibration variable than when it is a confounder. The full results are given in the Supplementary
Materials (S5.2). In general, we see that the differences between RILR and FILR tend to be smaller
when there are fewer centers (m = 6 vs. m = 500), σ2f(c) is small, or σ
2
γc is large.
The superior performance of FILR persisted even when we considered situations where there were
500 centers and, on average, 7−12% were concordant (Supplementary Material S5.2). In simulations
not designed specifically to have high concordance, up to 2% of centers were concordant, on
average.
Finally, we evaluated the estimate of the overall fixed intercept provided by RILR and found
absolute biases of more than 20% in many scenarios (Supplementary Material S5.2).
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Figure 3: Simulation results comparing random and fixed intercept logistic regression for m = 500
in the training data, where F = Normal, σ2γc = 1, σ
2
f(c) = 5, γc = 0.5 when center was a calibration
variable, and δ = −0.5 when center was a confounder. The median and interquartile ranges across
the simulations are reported. The columns in each plot correspond to different roles for center. The
results based on FILR are displayed as blue triangles and the results based on RILR are displayed as
red circles. The results for the biomarker coefficients are shown in the first two plots, and the results
for the AUC in a single new test center are shown in the third plot. In each plot, the dashed horizontal
line indicates the true value.
We have provided the R functions used to conduct these simulations in the Supplementary Material
(S6).
6 Application to the TRIBE-AKI Study
We applied the methods we have discussed to data from the TRIBE-AKI study. Recall that this is a
study of 1219 adults undergoing cardiac surgery at six medical centers, and there is interest in using
biomarkers to provide an earlier diagnosis of post-operative AKI. All participants provided written
informed consent and details regarding subject recruitment and sample collection and storage have
been previously reported.5 These data are used as illustration and not to report new findings of the
TRIBE-AKI study. We consider three biomarkers, urine NGAL, h-FABP, and plasma TNI, and use
the measurements taken immediately after surgery. After removing observations with missing values
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for any of these biomarkers, 962 observations remained. The three biomarkers were
log-transformed.
First we consider the role of center in this study. Since we are considering diagnostic biomarkers, we
evaluated the distribution of the biomarkers in each center among AKI controls. There is variation
in the distribution of the biomarker measurements across centers among controls (Figure 4).
Additionally, the center-specific AKI prevalences were between 7.8% and 22.9%. These results
strongly suggest that center is a confounder in this study.
Figure 4: Distribution of log urine NGAL, log plasma h-FABP, and log plasma TNI in the TRIBE-AKI
study among controls. The biomarker distributions are stratified by center.
We constructed linear biomarker combinations and evaluated their performance by estimating the
center-adjusted AUC. We corrected this estimate for optimism due to resubstitution bias by
bootstrapping the individual observations.
The biomarker combination estimated by FILR was
0.025 ∗ log(NGAL) + 1.103 ∗ log(h-FABP)− 0.065 ∗ log(TNI).
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The optimism-corrected center-adjusted AUC for this combination was 0.6823. The combination
estimated by RILR was
0.054 ∗ log(NGAL) + 1.096 ∗ log(h-FABP)− 0.065 ∗ log(TNI).
The optimism-corrected center-adjusted AUC for this combination was 0.6806. When center was
ignored during construction, the estimated combination was
0.081 ∗ log(NGAL) + 1.103 ∗ log(h-FABP)− 0.094 ∗ log(TNI),
and the optimism-corrected center-adjusted AUC for this combination was 0.6811. Thus, in these
data, the three fitted combinations were quite similar, and, correspondingly, the gains offered by
FILR in terms of the center-adjusted AUC were very modest.
7 Discussion
We have created a unified framework for constructing and evaluating biomarker combinations in
multicenter studies, including a taxonomy to differentiate the role center can play, tools for
identifying the role of center, and methods for constructing a biomarker combination and evaluating
its performance. Essentially, by conditioning on center in both the construction and evaluation of
biomarker combinations, we obtain combinations and measures of performance that are unaffected
by center differences. Given that such center differences are often not scientifically relevant and are
expected to vary in magnitude from center to center, using conditional approaches for construction
and evaluation of biomarker combinations is advised in order to avoid allowing center differences to
influence either the combination itself or the assessment of its performance. The concepts and
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methods we describe apply to biomarker combinations, and also to combinations of biomarkers and
other clinical or demographic variables.
The center-specific AUC may not be the same across centers; in this situation, it is generally
informative to evaluate the variability in the center-specific AUCs across center. This offers some
indication of how the biomarker combination might be expected to perform in a new center, if the
centers included in the evaluation are “similar” to the new centers. However, when assessing the
center-specific AUCs, it is important to keep in mind that AUC estimates from centers with fewer
observations are less reliable.
Different sampling schemes could affect the estimated weights wˆc, which could in turn affect the the
estimated center-adjusted AUC. The center-specific AUC itself is unaffected by case-control
sampling within each center41 and the center-adjusted AUC is unaffected by center-dependent
sampling among controls,35 though the asymptotic results we have provided may not hold under
certain sampling schemes. If a multicenter study also involves matching, care must be taken to
adjust the AUC for the matching in addition to center.34
Future research will consider approaches that do not rely on empirical estimates of the AUC, perhaps
by modeling the fitted combination parametrically (e.g., using a model to relate the combination to
center among controls);36 such an approach may be useful when there are a large number of very
small centers, as might happen when the “centers” are clinicians. In these settings, the empirical
AUC estimate may be unreliable, and an alternative estimate may be preferable.
An important contribution of this work is that it demonstrates that methods often applied to
multicenter biomarker data are frequently not appropriate. Biomarkers hold great potential for use
as diagnostic and prognostic tools, but have for the most part been relatively disappointing thus far.
Much of the problem has been blamed on “validation failures”; that is, biomarkers that are found to
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be quite promising initially, but are never used in clinical practice due to disappointing results in
follow-up studies.48 Thus, to the extent possible, it is important to recognize aspects of study
design, conduct, and analysis that require special attention when developing biomarker
combinations. Carefully addressing these issues can increase the likelihood of identifying clinically
useful combinations, ultimately leading to improvements in patient care.
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